| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9793 |
| Human Intestinal Absorption | HIA+ | 0.9920 |
| Caco-2 Permeability | Caco2- | 0.5827 |
| P-glycoprotein Substrate | Non-substrate | 0.6253 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9195 |
| Non-inhibitor | 0.9322 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8816 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6189 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6918 |
| CYP450 2D6 Substrate | Non-substrate | 0.8280 |
| CYP450 3A4 Substrate | Non-substrate | 0.6660 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8316 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9702 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9382 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9351 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9327 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9907 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9050 |
| Non-inhibitor | 0.8839 |
| AMES Toxicity | Non AMES toxic | 0.8194 |
| Carcinogens | Non-carcinogens | 0.9483 |
| Fish Toxicity | Low FHMT | 0.8097 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9078 |
| Honey Bee Toxicity | Low HBT | 0.7597 |
| Biodegradation | Ready biodegradable | 0.5517 |
| Acute Oral Toxicity | III | 0.4984 |
| Carcinogenicity (Three-class) | Non-required | 0.6995 |